Events
Company receives award in healthcare category for cancer therapy in clinical development with an action on cancer stem cells
NOXXON Pharma N.V. announced today the details of its participation at the ESMO Immuno-Oncology Congress on December 13-16, 2018 at the Palexpo Exhibition Center, 30 Route François-Peyrot, 1218 Le Grand-Saconnex, in Geneva, Switzerland.
The Best Biotech Entrepreneur Award® goes to Gilles Avenard, CEO of Acticor Biotech
MorphoSys AG announced today that according to the title of a presentation to be held next Wednesday afternoon CET (December 12, 2018) at the upcoming Inflammatory Skin Disease Summit (ISDS) conference in Vienna, Austria, guselkumab [Tremfya(R)] demonstrates superior long-term responses to secukinumab [Cosentyx(R)] at Week 48 in the treatment of moderate to severe psoriasis, as results from the ECLIPSE trial.
Glassdoor, one of the world’s largest job and recruiting sites, has announced the winners of its 11th annual Employees’ Choice Awards, honoring the Best Places to Work in 2019 across North America and parts of Europe
Dermavant Sciences today announced that the company will present new data on cerdulatinib during the 3rd Annual Inflammatory Skin Disease Summit (ISDS) taking place Dec. 12-15, 2018, in Vienna, Austria.
ADNEC and Abu Dhabi Convention Bureau collaborate to attract key conferences to the capital
he Ministry of Health and Prevention recently met with a Chinese delegation to discuss mutually beneficial cooperation in the use of technological innovations such as artificial intelligence (AI) in the health care sector.
Medigene AG announced that researchers from Oslo University Hospital presented an update on clinical compassionate use (1) data of their dendritic cell (DC) vaccine utilizing Medigene’s DC vaccine technology for production.
PRESS RELEASES